Literature DB >> 14981897

Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro.

Mario Turriziani1, Anna Maria Di Giacomo, Anna Cardillo, Francesco Torino, Lucio Tentori, Paola Nasuti, Maria Chiara Massara, Mario Roselli, Enzo Bonmassar, Liana De Vecchis.   

Abstract

BACKGROUND: Residual telomerase activity (TA) could be used as a marker of malignant or normal cell survival after exposure to cytotoxic agents. Therefore TA after treatment with ionizing radiation was used in a radiosensitivity assay.
MATERIALS AND METHODS: Radiosensitive MOLT-4 and relatively radioresistant Jurkat leukemia cells or normal peripheral blood mononuclear cells (MNC) were irradiated with 5-160 Gy. Cell count, MTT assay and telomerase activity were evaluated on day 3 and clonogenic assay on day 10.
RESULTS: In Jurkat cells, irradiation inhibited tumor growth and total TA per culture (TA/culture), but up-regulated TA per viable cell (TA/cell). TA/culture and TA/cell were profoundly depressed by irradiation of MOLT-4 or phytohemagglutinin-activated MNC.
CONCLUSION: Susceptibility of normal or neoplastic cells to high-dose radiation can be monitored by evaluating residual TA/culture. In some cases, however, difficulties in the interpretation of the results could stem from radiation-induced increase of TA/cell, as observed for the Jurkat cell line.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14981897

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines.

Authors:  P Millet; C Granotier; O Etienne; F D Boussin
Journal:  Int J Oncol       Date:  2013-05-31       Impact factor: 5.650

2.  Transcriptional analysis of normal human fibroblast responses to microgravity stress.

Authors:  Yongqing Liu; Eugenia Wang
Journal:  Genomics Proteomics Bioinformatics       Date:  2008-03       Impact factor: 7.691

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.